CryoStasis

International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem cells. ISCO is actively engaged in developing specialized cell types, such as neural stem cells, which hold promise for treating Parkinson's disease and other disorders affecting the central nervous system. Beyond therapeutics, the company also develops, manufactures, and commercializes anti-aging skincare products and an extensive range of human cell culture products. Its diverse portfolio of human cell culture products serves as vital research tools across numerous scientific disciplines. This includes specialized cells and reagents designed for studying: Dermatology: Skin diseases, toxicology, and wound healing. Cardiovascular & Oncology: Heart and blood vessel conditions, and various cancers. Respiratory: Bronchial and tracheal conditions, toxicity, cystic fibrosis, asthma, and pathogenesis. Reproductive & Urological: Prostate, renal, bladder, corneal, and female reproductive system diseases, as well as general cellular physiology. Musculoskeletal & Metabolic: Skeletal muscle biology, diabetes, insulin pathways, muscle repair, and myotube development. The company also provides adult stem cells for regenerative medicine research and a full complement of reagents and supplements essential for cell growth, staining, and cryopreservation. Distribution of ISCO's skincare range occurs via its website and specialized professional channels, while its human cell culture products reach customers through a dedicated sales force, original equipment manufacturer (OEM) partners, and authorized brand distributors. Established in 2001, International Stem Cell Corporation maintains its headquarters in San Diego, California.

AtelerixHealthTechUnited Kingdom

65% match

Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.

Obatala Sciences, Inc.HealthcareUnited States

62% matchPrivate

Obatala Sciences, Inc. is a biotechnology company that provides organ-on-a-chip solutions for research, with its office located in New Orleans, Louisiana.

SpiderwortBioTechCanada

69% match

Spiderwort Biotechnologies Inc. is an Ottawa-based biotechnology innovator specializing in all-natural, plant-based biomaterials designed to support tissue regeneration and repair spinal cord injuries.

BMI OrganBank is a medical device and biotechnology company developing next-generation organ and tissue transplant solutions.

General BioTechnology LLC provides biomedical research, specializing in the development of cryo-preservation and banking methods for diverse cells.